Package 47335-954-83

{"route": ["ORAL"], "spl_id": "5054c941-5817-4666-b562-800de8be86b2", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["e4e38abf-ef67-405b-af2d-3d8e4533654d"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-13)", "package_ndc": "47335-954-13", "marketing_start_date": "20141225"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-81)", "package_ndc": "47335-954-81", "marketing_start_date": "20141225"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-83)", "package_ndc": "47335-954-83", "marketing_start_date": "20141225"}], "brand_name": "Bupropion Hydrochloride", "product_id": "47335-954_5054c941-5817-4666-b562-800de8be86b2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "47335-954", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA200695", "marketing_category": "ANDA", "marketing_start_date": "20141225", "listing_expiration_date": "20261231"}